GH
Guardant Health IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$17.45B
P/E Ratio
—
EPS
$-3.40
Beta
1.62
52W High
$134.28
52W Low
$40.35
50-Day MA
$102.83
200-Day MA
$92.63
Dividend Yield
—
Profit Margin
-40.10%
Forward P/E
—
PEG Ratio
—
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $1.08B |
| Gross Profit (TTM) | $701.01M |
| EBITDA | $-408.16M |
| Operating Margin | -40.20% |
| Return on Equity | -4584.00% |
| Return on Assets | -17.20% |
| Revenue/Share (TTM) | $8.49 |
| Book Value | $-1.38 |
| Price-to-Book | 55.67 |
| Price-to-Sales (TTM) | 16.16 |
| EV/Revenue | 16.72 |
| EV/EBITDA | -5.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 48.30% |
| Shares Outstanding | $132.60M |
| Float | $127.92M |
| % Insiders | 4.03% |
| % Institutions | 105.88% |
Historical Volatility
HV 10-Day
47.02%
HV 20-Day
71.15%
HV 30-Day
60.59%
HV 60-Day
61.92%
HV Rank
67.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($140.91 target)
4
Strong Buy16
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026